Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

18FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy

NCT03741231 is registered in ClinicalTrials.gov with University Hospital, Brest as lead sponsor.

NCT NCT03741231
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03741231 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
18FluoroDeoxyGlucose-Positron Emission Tomography (PET) in Patients With Melanoma or Non Small Cell Lung Cancer Treated With Immunotherapy
Lead sponsor
University Hospital, Brest
Phase
Observational
Overall status
Completed
Start date
March 1, 2018
Completion date
June 30, 2018
Enrollment
70 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

18f-fdg, immunotherapy, melanoma, nsclc, positron-emission tomography